Pure and Applied Chemistry

CrossRef Cited-by Linking

• Irie Kazuhiro, Yanagita Ryo C.: Synthesis and Biological Activities of Simplified Analogs of the Natural PKC Ligands, Bryostatin-1 and Aplysiatoxin. The Chemical Record 2014, n/a. <http://dx.doi.org/10.1002/tcr.201300036>
• Dostál V., Libusová L.: Microtubule drugs: action, selectivity, and resistance across the kingdoms of life. Protoplasma 2014. <http://dx.doi.org/10.1007/s00709-014-0633-0>
• Aeluri Madhu, Chamakuri Srinivas, Dasari Bhanudas, Guduru Shiva Krishna Reddy, Jimmidi Ravikumar, Jogula Srinivas, Arya Prabhat: Small Molecule Modulators of Protein–Protein Interactions: Selected Case Studies. Chem. Rev. 2014, 140327132710004. <http://dx.doi.org/10.1021/cr4004049>
• Ueda Atsushi, Yamamoto Akihiko, Kato Daisuke, Kishi Yoshito: Total Synthesis of Halichondrin A, the Missing Member in the Halichondrin Class of Natural Products. J. Am. Chem. Soc. 2014, 136, 5171. <http://dx.doi.org/10.1021/ja5013307>
• Bauer Armin, Brönstrup Mark: Industrial natural product chemistry for drug discovery and development. Nat. Prod. Rep. 2014, 31, 35. <http://dx.doi.org/10.1039/c3np70058e>
• Kuttruff Christian A., Eastgate Martin D., Baran Phil S.: Natural product synthesis in the age of scalability. Nat. Prod. Rep. 2014, 31, 419. <http://dx.doi.org/10.1039/c3np70090a>
• Blunt John W., Copp Brent R., Keyzers Robert A., Munro Murray H. G., Prinsep Michèle R.: Marine natural products. Nat. Prod. Rep. 2014, 31, 160. <http://dx.doi.org/10.1039/c3np70117d>
• Da Silva Pierre P.J., Bendjeddou Lyamin Z., Meijer Laurent: Recherche de substances naturelles à activité thérapeutique (2). Med Sci (Paris) 2014, 30, 319. <http://dx.doi.org/10.1051/medsci/20143003021>
• Rubiolo J A, López-Alonso H, Roel M, Vieytes M R, Thomas O, Ternon E, Vega F V, Botana L M: Mechanism of cytotoxic action of crambescidin-816 on human liver-derived tumour cells. Br J Pharmacol 2014, 171, 1655. <http://dx.doi.org/10.1111/bph.12552>
• Ramaswami Ramya, O’Cathail Sean M, Brindley James H, Silcocks Paul, Mahmoud Sarah, Palmieri Carlo: Activity of eribulin mesylate in heavily pretreated breast cancer granted accessvia the Cancer Drugs Fund. Future Oncology 2014, 10, 363. <http://dx.doi.org/10.2217/fon.13.210>
• Fernandes Rodney A., Halle Mahesh B.: Total Synthesis of Both Spiroketal Diastereomers of the Reported Structure of Cephalosporolide H. Asian Journal of Organic Chemistry 2013, 2, 593. <http://dx.doi.org/10.1002/ajoc.201300067>
• Gerwick William H., Fenner Amanda M.: Drug Discovery from Marine Microbes. Microb Ecol 2013, 65, 800. <http://dx.doi.org/10.1007/s00248-012-0169-9>
• Giddings Lesley-Ann, Newman David J.: Microbial natural products: molecular blueprints for antitumor drugs. J Ind Microbiol Biotechnol 2013, 40, 1181. <http://dx.doi.org/10.1007/s10295-013-1331-1>
• Svenson Johan: MabCent: Arctic marine bioprospecting in Norway. Phytochem Rev 2013, 12, 567. <http://dx.doi.org/10.1007/s11101-012-9239-3>
• Kawabata Takenori, Lindsay Dhugal J., Kitamura Minoru, Konishi Satoshi, Nishikawa Jun, Nishida Shuhei, Kamio Michiya, Nagai Hiroshi: Evaluation of the bioactivities of water-soluble extracts from twelve deep-sea jellyfish species. Fish Sci 2013, 79, 487. <http://dx.doi.org/10.1007/s12562-013-0612-y>
• Hahn Dongyup, Won Dong Hwan, Mun Bora, Kim Hiyoung, Han Chulkyeong, Wang Weihong, Chun Taeho, Park Sunhee, Yoon Dajeong, Choi Hyukjae, Nam Sang-Jip, Ekins Merrick, Chin Jungwook, Kang Heonjoong: Cytotoxic scalarane sesterterpenes from a Korean marine sponge Psammocinia sp. Bioorganic & Medicinal Chemistry Letters 2013, 23, 2336. <http://dx.doi.org/10.1016/j.bmcl.2013.02.061>
• Rudolph Alena, Alberico Dino, Jordan Robert, Pan Ming, Souza Fabio E.S., Gorin Boris: Early introduction of the amino group to the C27–C35 building block of Eribulin. Tetrahedron Letters 2013, 54, 7059. <http://dx.doi.org/10.1016/j.tetlet.2013.10.077>
• Britton Robert, Kang Baldip: α-Haloaldehydes: versatile building blocks for natural product synthesis. Nat. Prod. Rep. 2013, 30, 227. <http://dx.doi.org/10.1039/c2np20108a>
• Yu Melvin J., Zheng Wanjun, Seletsky Boris M.: From micrograms to grams: scale-up synthesis of eribulin mesylate. Nat. Prod. Rep. 2013, 30, 1158. <http://dx.doi.org/10.1039/c3np70051h>
• Turk Tom, Avguštin Jerneja, Batista Urška, Strugar Gašper, Kosmina Rok, Čivović Sandra, Janussen Dorte, Kauferstein Silke, Mebs Dietrich, Sepčić Kristina: Biological Activities of Ethanolic Extracts from Deep-Sea Antarctic Marine Sponges. Marine Drugs 2013, 11, 1126. <http://dx.doi.org/10.3390/md11041126>
• Jones Amy, Grkovic Tanja, Sykes Melissa, Avery Vicky: Trypanocidal Activity of Marine Natural Products. Marine Drugs 2013, 11, 4058. <http://dx.doi.org/10.3390/md11104058>
• Shablak Alaaeldin: Eribulin for Advanced Breast Cancer: A Drug Evaluation. J Breast Cancer 2013, 16, 12. <http://dx.doi.org/10.4048/jbc.2013.16.1.12>
• Seligmann Jenny, Twelves Chris: Tubulin: an example of targeted chemotherapy. Future Medicinal Chemistry 2013, 5, 339. <http://dx.doi.org/10.4155/fmc.12.217>
• Noro Jeffery C., Kalaitzis John A., Neilan Brett A.: Bioactive Natural Products from Papua New Guinea Marine Sponges. Chemistry & Biodiversity 2012, 9, 2077. <http://dx.doi.org/10.1002/cbdv.201100292>
• Murthy Akondi Srirama, Mahipal Bodugum, Chandrasekhar Srivari: Asymmetric Synthesis of the C14-C26 Building Block of Eribulin Mesylate. Eur. J. Org. Chem. 2012, 2012, 6959. <http://dx.doi.org/10.1002/ejoc.201201119>
• Ottinger Sabine, Klöppel Anne, Rausch Vanessa, Liu Li, Kallifatidis Georgios, Gross Wolfgang, Gebhard Martha-Maria, Brümmer Franz, Herr Ingrid: Targeting of pancreatic and prostate cancer stem cell characteristics by Crambe crambe marine sponge extract. Int J Cancer (Radiat Oncol Invest) 2012, 130, 1671. <http://dx.doi.org/10.1002/ijc.26168>
• Yu Melvin J., Zheng Wanjun, Tendyke Karen: Atom-based enumeration: New eribulin analogues with low susceptibility to P-glycoprotein-mediated drug efflux. Bioorganic & Medicinal Chemistry Letters 2012, 22, 7363. <http://dx.doi.org/10.1016/j.bmcl.2012.10.077>
• Moore Bradley S., Gerwick William H.: Lessons from the Past and Charting the Future of Marine Natural Products Drug Discovery and Chemical Biology. Chem and Biol 2012, 19, 85. <http://dx.doi.org/10.1016/j.chembiol.2011.12.014>
• Spira Alexander I., Iannotti Nicholas O., Savin Michael A., Neubauer Marcus, Gabrail Nashat Y., Yanagihara Ronald H., Zang Edith A., Cole Patricia E., Shuster Dale, Das Asha: A Phase II Study of Eribulin Mesylate (E7389) in Patients With Advanced, Previously Treated Non–Small-Cell Lung Cancer. Clin Lung Cancer 2012, 13, 31. <http://dx.doi.org/10.1016/j.cllc.2011.06.010>
• Swami Umang, Chaudhary Imran, Ghalib Mohammad H., Goel Sanjay: Eribulin—A review of preclinical and clinical studies. Critical Reviews in Oncology and Hematology 2012, 81, 163. <http://dx.doi.org/10.1016/j.critrevonc.2011.03.002>
• Cortes Javier, Montero Alberto J., Glück Stefan: Eribulin mesylate, a novel microtubule inhibitor in the treatment of breast cancer. cancer treatment rev 2012, 38, 143. <http://dx.doi.org/10.1016/j.ctrv.2011.03.006>
• Poujol S., Dell’ova M., Bekhtari K., Bressolle F., Pinguet F.: Stability of the ready-to-use solutions of eribulin for intravenous infusion. Annales Pharmaceutiques Françaises 2012, 70, 249. <http://dx.doi.org/10.1016/j.pharma.2012.06.004>
• Molinski Tadeusz F., Morinaka Brandon I.: Integrated approaches to the configurational assignment of marine natural products. Tetrahedron 2012, 68, 9307. <http://dx.doi.org/10.1016/j.tet.2011.12.070>
• Yadav J.S., Nagendra Reddy C., Sabitha G.: Synthesis of the C38�C54 spiroketal segment of halichondrin B. Tetrahedron Letters 2012, 53, 2504. <http://dx.doi.org/10.1016/j.tetlet.2012.02.090>
• Yamamoto Akihiko, Ueda Atsushi, Brémond Paul, Tiseni Paolo S., Kishi Yoshito: Total Synthesis of Halichondrin C. J. Am. Chem. Soc. 2012, 134, 893. <http://dx.doi.org/10.1021/ja2108307>
• Shan Mingde, Kishi Yoshito: Concise and Highly Stereoselective Synthesis of the C20–C26 Building Block of Halichondrins and Eribulin. Org Lett 2012, 14, 660. <http://dx.doi.org/10.1021/ol203373d>
• Zhu Liangyu, Song Liyan, Tong Rongbiao: Diastereoselective Reductive Ring Expansion of Spiroketal Dihydropyranones to cis-Fused Bicyclic Ethers. Org. Lett. 2012, 14, 5892. <http://dx.doi.org/10.1021/ol302813e>
• Sabitha Gowravaram, Chandrashekhar Gajangi, Yadav Jhillu Singh, Rachineni Kavitha, Jagadeesh Bharatam: Synthesis of the C45–C53 tetrahydropyran domain of norhalichondrins and the C14–C22 tetrahydrofuran domain of the halichondrin family. RSC Adv. 2012, 2, 10157. <http://dx.doi.org/10.1039/c2ra21346j>
• Ueda Minoru: Chemical Biology of Natural Products on the Basis of Identification of Target Proteins. Chem. Lett. 2012, 41, 658. <http://dx.doi.org/10.1246/cl.2012.658>
• ABE Takahiro, SAHIN Fatma Pinar, AKIYAMA Kiyotaka, NAITO Takayuki, KISHIGAMI Mizoe, MIYAMOTO Kenji, SAKAKIBARA Yasufumi, UEMURA Daisuke: Construction of a Metagenomic Library for the Marine Sponge Halichondria okadai. Biosciences Biotechnology and Biochemistry 2012, 76, 633. <http://dx.doi.org/10.1271/bbb.110533>
• Uemura Daisuke, Han Chunguang, Hanif Novriyandi, Inuzuka Toshiyasu, Maru Norihito, Arimoto Hirokazu: Recent insights into natural venoms. PureAppl Chem 2012, 1. <http://dx.doi.org/10.1351/PAC-CON-11-09-32>
• LaBarbera Daniel V, Reid Brian G, Yoo Byong Hoon: The multicellular tumor spheroid model for high-throughput cancer drug discovery. Expert Opin. Drug Discov. 2012, 7, 819. <http://dx.doi.org/10.1517/17460441.2012.708334>
• Fuwa Haruhiko: Total Synthesis of Tetrahydropyran-Containing Natural Products Exploiting Intramolecular Oxa-Conjugate Cyclization. HETEROCYCLES 2012, 85, 1255. <http://dx.doi.org/10.3987/REV-12-730>
• Gourmelon Carole, Frenel Jean Sébastien, Campone Mario: Clinical evidence for the role of eribulin mesylate in the treatment of breast cancer. Clinical Investigation 2012, 2, 207. <http://dx.doi.org/10.4155/cli.11.173>
• Pandey Kartikay: Potent bioactive compounds from the ocean: some interesting aspects and applications. Pharmacognosy Journal 2012, 4, 1. <http://dx.doi.org/10.5530/pj.2012.27.1>
• Qi Yunkun, Ma Shutao: The Medicinal Potential of Promising Marine Macrolides with Anticancer Activity. ChemMedChem 2011, 6, 399. <http://dx.doi.org/10.1002/cmdc.201000534>
• Arnold Susanne M., Moon James, Williamson Stephen K., Atkins James N., Ou Sai-Hong I., LeBlanc Michael, Urba Susan G.: Phase II evaluation of eribulin mesylate (E7389, NSC 707389) in patients with metastatic or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group trial S0618. Invest New Drugs 2011, 29, 352. <http://dx.doi.org/10.1007/s10637-009-9348-z>
• Aftimos Philippe, Awada Ahmad: Survival benefit of eribulin mesylate in heavily pretreated metastatic breast cancer: What next?. Adv Therapy 2011, 28, 973. <http://dx.doi.org/10.1007/s12325-011-0070-9>
• Brooke Darby G., Shelley Elizabeth J., Roberts Caroline G., Denny William A., Sutherland Robert L., Butt Alison J.: Synthesis and in vitro evaluation of analogues of avocado-produced toxin (+)-(R)-persin in human breast cancer cells. Bioorganic Medicinal Chemistry 2011, 19, 7033. <http://dx.doi.org/10.1016/j.bmc.2011.10.006>
• Yeung Bryan KS: Natural product drug discovery: the successful optimization of ISP-1 and halichondrin B. Curr Opin Chem Biol 2011, 15, 523. <http://dx.doi.org/10.1016/j.cbpa.2011.05.019>
• Ohno Osamu, Chiba Tatsuhiko, Todoroki Seiji, Yoshimura Hideaki, Maru Norihito, Maekawa Ken, Imagawa Hiroshi, Yamada Kaoru, Wakamiya Atsushi, Suenaga Kiyotake: Halichonines A, B, and C, novel sesquiterpene alkaloids from the marine sponge Halichondria okadai Kadota. Chem Commn 2011, 47, 12453. <http://dx.doi.org/10.1039/c1cc15557a>
• Carter Guy T.: Natural products and Pharma 2011: Strategic changes spur new opportunities. Natural Products Report 2011, 28, 1783. <http://dx.doi.org/10.1039/c1np00033k>
• Gourmelon Carole, Frenel Jean Sébastien, Campone Mario: Eribulin mesylate for the treatment of late-stage breast cancer. Expert Opinion Pharmacotherapy 2011, 12, 2883. <http://dx.doi.org/10.1517/14656566.2011.637490>
• Perry Caroline M.: Eribulin : . Drug 2011, 71, 1321. <http://dx.doi.org/10.2165/11207520-000000000-00000>
• Cortes Javier, Lorca Rebeca: Eribulin mesylate: a promising new antineoplastic agent for locally advanced or metastatic breast cancer. Future Oncology 2011, 7, 355. <http://dx.doi.org/10.2217/fon.10.186>
• Guancial Elizabeth A, Chowdhury Dipanjan, Rosenberg Jonathan E: Personalized therapy for urothelial cancer: review of the clinical evidence. Clinical Investigation 2011, 1, 543. <http://dx.doi.org/10.4155/cli.11.26>
• Montaser Rana, Luesch Hendrik: Marine natural products: a new wave of drugs?. Future Medicinal Chemistry 2011, 3, 1475. <http://dx.doi.org/10.4155/fmc.11.118>
• Chiba Hiroyuki, Tagami Katsuya: Research and Development of HALAVEN(Eribulin Mesylate). J Syn Org Chem Jpn 2011, 69, 600. <http://dx.doi.org/10.5059/yukigoseikyokaishi.69.600>
• Alvarez Eleuterio, Díaz Maria Teresa, Zurita Dácil, Zárraga Miguel, Martín Julio D.: Model Studies Directed Towards Microalga Polyether Toxins. Bull Soc Chim Belges 2010, 99, 635. <http://dx.doi.org/10.1002/bscb.19900990904>
• La Clair James J.: Natural product mode of action (MOA) studies: a link between natural and synthetic worlds. Nat Prod Rep 2010, 27, 969. <http://dx.doi.org/10.1039/b909989c>
• Morris Patrick G.: Advances in therapy: eribulin improves survival for metastatic breast cancer : . Anticancer Drugs 2010, 21, 885. <http://dx.doi.org/10.1097/CAD.0b013e32833ed62e>
• Sepčić Kristina, Kauferstein Silke, Mebs Dietrich, Turk Tom: Biological Activities of Aqueous and Organic Extracts from Tropical Marine Sponges. Marine Drugs 2010, 8, 1550. <http://dx.doi.org/10.3390/md8051550>
• Jackson Katrina L., Henderson James A., Motoyoshi Hajime, Phillips Andrew J.: A Total Synthesis of Norhalichondrin B. Angew Chem 2009, 121, 2382. <http://dx.doi.org/10.1002/ange.200806111>
• Jackson Katrina L., Henderson James A., Motoyoshi Hajime, Phillips Andrew J.: A Total Synthesis of Norhalichondrin B. Angew Chem Int E 2009, 48, 2346. <http://dx.doi.org/10.1002/anie.200806111>
• Hickford Sarah J.H., Blunt John W., Munro Murray H.G.: Antitumour polyether macrolides: Four new halichondrins from the New Zealand deep-water marine sponge Lissodendoryx sp. biorg med chem 2009, 17, 2199. <http://dx.doi.org/10.1016/j.bmc.2008.10.093>
• Kim Dae-Shik, Dong Cheng-Guo, Kim Joseph T., Guo Haibing, Huang Jian, Tiseni Paolo S., Kishi Yoshito: New Syntheses of E7389 C14−C35 and Halichondrin C14−C38 Building Blocks: Double-Inversion Approach. J Am Chem Soc 2009, 131, 15636. <http://dx.doi.org/10.1021/ja9058475>
• Molinski Tadeusz F., Dalisay Doralyn S., Lievens Sarah L., Saludes Jonel P.: Drug development from marine natural products. Nat Rev Drug Discov 2009, 8, 69. <http://dx.doi.org/10.1038/nrd2487>
• Nagarajan Subbiah, Mohan Das Thangamuthu, Arjun Pandian, Raaman Nanjian: Design, synthesis and gelation studies of 4,6-O-butylidene-α,β-unsaturated-β-C-glycosidic ketones: application to plant tissue culture. J Mater Chem 2009, 19, 4587. <http://dx.doi.org/10.1039/b902064k>
• Nagarajan Subbiah, Mohan Das Thangamuthu: A sugar–pyrene-based fluorescent gelator: nanotubular architecture and interaction with SWCNTs. New J Chem 2009, 33, 2391. <http://dx.doi.org/10.1039/b9nj00395a>
• Silvestre Francesco, Tosti Elisabetta: Impact of Marine Drugs on Animal Reproductive Processes. Marine Drugs 2009, 7, 539. <http://dx.doi.org/10.3390/md7040539>
• HUANG Xiao-Chun, LIU Hai-Li, GUO Yue-Wei: Biemna fortisTopsent]]> : Chemical Constituents of Marine Sponge Biemna fortisTopsent. CJNM 2009, 6, 348. <http://dx.doi.org/10.3724/SP.J.1009.2008.00348>
• Uemura Daisuke, Nakamura Kazuhiko, Kitamura Makoto: Biologically Active Marine Natural Products. HETEROCYCLES 2009, 78, 1. <http://dx.doi.org/10.3987/REV-08-637>
• Bisht Surendra Singh, Pandey Jyoti, Sharma Anindra, Tripathi Rama Pati: Aldol reaction of β-C-glycosylic ketones: synthesis of C-(E)-cinnamoyl glycosylic compounds as precursors for new biologically active C-glycosides. Carbohydrates Research 2008, 343, 1399. <http://dx.doi.org/10.1016/j.carres.2008.04.021>
• Jackson Katrina L., Henderson James A., Morris Jonathan C., Motoyoshi Hajime, Phillips Andrew J.: A synthesis of the C1–C15 domain of the halichondrins. Tetrahetron Lett 2008, 49, 2939. <http://dx.doi.org/10.1016/j.tetlet.2008.03.018>
• Butler Mark S.: Natural products to drugs: natural product-derived compounds in clinical trials. Nat Prod Rep 2008, 25, 475. <http://dx.doi.org/10.1039/b514294f>
• Kumar Pradeep, Naidu Vasudeva, Gupta Priti: Application of hydrolytic kinetic resolution (HKR) in the synthesis of bioactive compounds. Tetrahedron 2007, 63, 2745. <http://dx.doi.org/10.1016/j.tet.2006.12.015>
• Bowling John J, Kochanowska Anna J, Kasanah Noer, Hamann Mark T: Nature's bounty – drug discovery from the sea. Expert Opin Drug Discov 2007, 2, 1505. <http://dx.doi.org/10.1517/17460441.2.11.1505>
• Sipkema Detmer, Osinga Ronald, Schatton Wolfgang, Mendola Dominick, Tramper Johannes, Wijffels René H.: Large-scale production of pharmaceuticals by marine sponges: Sea, cell, or synthesis?. Biotechnol Bioeng 2005, 90, 201. <http://dx.doi.org/10.1002/bit.20404>
• Sipkema Detmer, Franssen Maurice C. R., Osinga Ronald, Tramper Johannes, Wijffels René H.: Marine Sponges as Pharmacy. Mar Biotechnol 2005, 7, 142. <http://dx.doi.org/10.1007/s10126-004-0405-5>
• Keller Valerie A., Kim Ikyon, Burke Steven D.: Synthetic Efforts toward the C22−C36 Subunit of Halichondrin B Utilizing Local and Imposed Symmetry. Org Lett 2005, 7, 737. <http://dx.doi.org/10.1021/ol0473400>
• Butler Mark S.: Natural products to drugs: natural product derived compounds in clinical trials. Nat Prod Rep 2005, 22, 162. <http://dx.doi.org/10.1039/b402985m>
• Seletsky Boris M., Wang Yuan, Hawkins Lynn D., Palme Monica H., Habgood Gregory J., DiPietro Lucian V., Towle Murray J., Salvato Kathleen A., Wels Bruce F., Aalfs Kimberley K.: Structurally simplified macrolactone analogues of halichondrin B. Biorg Med Chem Lett 2004, 14, 5547. <http://dx.doi.org/10.1016/j.bmcl.2004.08.068>
• Zheng Wanjun, Seletsky Boris M., Palme Monica H., Lydon Paul J., Singer Lori A., Chase Charles E., Lemelin Charles A., Shen Yongchun, Davis Heather, Tremblay Lynda: Macrocyclic ketone analogues of halichondrin B. Biorg Med Chem Lett 2004, 14, 5551. <http://dx.doi.org/10.1016/j.bmcl.2004.08.069>
• Prado M.P., Torres Y.R., Berlinck R.G.S., Desiderá C., Sanchez M.A., Craveiro M.V., Hajdu E., da Rocha R.M., Machado-Santelli G.M.: Effects of marine organisms extracts on microtubule integrity and cell cycle progression in cultured cells. J Expl Mar Biol Ecol 2004, 313, 125. <http://dx.doi.org/10.1016/j.jembe.2004.08.008>
• Lambert William T., Burke Steven D.: Halichondrin B:  Synthesis of a C1−C14 Model via Desymmetrization of (+)-Conduritol E. Org Lett 2003, 5, 515. <http://dx.doi.org/10.1021/ol027389a>
• Schwartsmann Gilberto, da Rocha Adriana Brondani, Mattei Jane, Lopes RafaelMartins: Marine-derived anticancer agents in clinical trials. Expert Opin Invest Drugs 2003, 12, 1367. <http://dx.doi.org/10.1517/13543784.12.8.1367>
• Austad Brian C, Hart Amy C, Burke Steven D: Halichondrin B: synthesis of the C(37)–C(54) subunit. Tetrahedron 2002, 58, 2011. <http://dx.doi.org/10.1016/S0040-4020(02)00050-9>
• Kishi Yoshito: Palytoxin: an inexhaustible source of inspiration—personal perspective. Tetrahedron 2002, 58, 6239. <http://dx.doi.org/10.1016/S0040-4020(02)00624-5>
• Jiang Lei, Burke Steven D.: A Novel Route to the F-Ring of Halichondrin B. Diastereoselection in Pd(0)-Mediated meso and C₂ Diol Desymmetrization. Org Lett 2002, 4, 3411. <http://dx.doi.org/10.1021/ol026504e>
• Wan Zhao-Kui, Choi Hyeong-wook, Kang Fu-An, Nakajima Katsumasa, Demeke Damtew, Kishi Yoshito: Asymmetric Ni(II)/Cr(II)-Mediated Coupling Reaction:  Stoichiometric Process. Org Lett 2002, 4, 4431. <http://dx.doi.org/10.1021/ol0269805>
• Munro Murray H.G., Blunt John W., Dumdei Eric J., Hickford Sarah J.H., Lill Rachel E., Li Shangxiao, Battershill Christopher N., Duckworth Alan R.: The discovery and development of marine compounds with pharmaceutical potential. J Biotechnol 1999, 70, 15. <http://dx.doi.org/10.1016/S0168-1656(99)00052-8>
• Jordan Allan, Hadfield John A., Lawrence Nicholas J., McGown Alan T.: Tubulin as a target for anticancer drugs: Agents which interact with the mitotic spindle. Med Res Rev 1998, 18, 259. <http://dx.doi.org/10.1002/(SICI)1098-1128(199807)18:4<259::AID-MED3>3.0.CO;2-U>
• Mechnich Oliver, Messier Gerhard, Kessler Horst, Bernd Michael, Kutscher Bernhard: Cyclic Heptapeptides Axinastatin 2, 3, and 4: Conformational analysis and evaluation of the biological potential. HCA 1997, 80, 1338. <http://dx.doi.org/10.1002/hlca.19970800503>
• König Gabriele M., Wright Anthony D.: Meeresorganismen - Produzenten pharmakologisch aktiver Sekundärstoffe. Pharm Unserer Zeit 1997, 26, 281. <http://dx.doi.org/10.1002/pauz.19970260608>
• Horita Kiyoshi, Nagasawa Masaaki, Hachiya Shun-ichiro, Sakurai Youji, Yamazaki Tatsuya, Uenishi Jun'ichi, Yonemitsu Osamu: Synthetic studies of halichondrin B, an antitumor polyether macrolide isolated from a marine sponge. 8. Synthesis of the lactone part (C1C36) via horner-emmons coupling between C1C15 and C16C36 fragments and Yamaguchi lactonization. Tetrahetron Lett 1997, 38, 8965. <http://dx.doi.org/10.1016/S0040-4039(97)10364-1>
• Fenical William: New pharmaceuticals from marine organisms. Trends in Biotechnol 1997, 15, 339. <http://dx.doi.org/10.1016/S0167-7799(97)01081-0>
• Stamos Dean P, Kishi Yoshito: Synthetic studies on halichondrins: A practical synthesis of the C.1C.13 segment. Tetrahetron Lett 1996, 37, 8643. <http://dx.doi.org/10.1016/S0040-4039(96)01999-5>
• Biomedical Potential of Marine Natural Products. BioScience 1996, 46, 271. <http://dx.doi.org/10.2307/1312834>
• Hoffmann Reinhard W., Mu¨nster Ingo: cis-Fuseddi- and tri-tetrahydropyrans by intramolecular allylboration reactions. Tetrahetron Lett 1995, 36, 1431. <http://dx.doi.org/10.1016/0040-4039(95)00013-3>
• Burke Steven D., Zhang Gan, Buchanan John L.: Enantioselective synthesis of a halichondrin B C(20)→C(36) precursor. Tetrahetron Lett 1995, 36, 7023. <http://dx.doi.org/10.1016/0040-4039(95)01454-P>
• Dorta Rosa L., Freire Raimundo, Martín Angeles, Suárez Ernesto, Prangé Thierry: Cis- and trans-fused Di-tetrahydropyrans by rearrangement of steroidal spiroacetals. Tetrahetron Lett 1995, 36, 7309. <http://dx.doi.org/10.1016/0040-4039(95)01472-T>
• Fujiwara Kenshu, Tokiwano Tetsuo, Murai Akio: La(otf)3-catalyzed 6-endo epoxide opening of 4, 5-epoxy-4-methoxymethyl-1-hexanols. Tetrahetron Lett 1995, 36, 8063. <http://dx.doi.org/10.1016/0040-4039(95)01709-Q>
• Burke Steven D., Woon Jung Kyung, Phillips Jeannie R., Perri Roman E.: An expeditious synthesis of the C(1)-C(14) subunit of halichondrin B. Tetrahetron Lett 1994, 35, 703. <http://dx.doi.org/10.1016/S0040-4039(00)75795-9>
• Litaudon Marc, Hart Joanne B, Blunt John W, Lake Robin J, Munro Murray hg: Isohomohalichondrin B, a new antitumour polyether macrolide from the New Zealand deep-water sponge Lissodendoryx sp. Tetrahetron Lett 1994, 35, 9435. <http://dx.doi.org/10.1016/S0040-4039(00)78563-7>
• Michael Joseph P., Pattenden Gerald: Marine Metaboliten und die Komplexierung von Metall-Ionen: Tatsachen und Hypothesen. Angew Chem 1993, 105, 1. <http://dx.doi.org/10.1002/ange.19931050104>
• Michael Joseph P., Pattenden Gerald: Marine Metabolites and Metal Ion Chelation: The Facts and the Fantasies. Angew Chem Int Ed Engl 1993, 32, 1. <http://dx.doi.org/10.1002/anie.199300013>
• Duan James J.-W., Kishi Yoshito: Synthetic studies on halichondrins: A new practical synthesis of the C.1–C.12 segment. Tetrahetron Lett 1993, 34, 7541. <http://dx.doi.org/10.1016/S0040-4039(00)60394-5>
• Cooper Arthur J., Pan Wenxi, Salomon Robert G.: Total synthesis of halichondrin b from common sugars: An F-ring intermediate from D-glucose and efficient construction of the C1 to C21 segment. Tetrahetron Lett 1993, 34, 8193. <http://dx.doi.org/10.1016/S0040-4039(00)61388-6>
• DiFranco Elso, Ravikumar Vasulinga T., Salomon Robert G.: Total synthesis of halichondrins: Enantioselective construction of a homochiral tetracyclic KLMN-ring intermediate from D-mannitol. Tetrahetron Lett 1993, 34, 3247. <http://dx.doi.org/10.1016/S0040-4039(00)73673-2>
• Sutherlin Daniel P., Amrstrong Robert W.: Stereoselective synthesis of dipyranyl C-disaccharides. Tetrahetron Lett 1993, 34, 4897. <http://dx.doi.org/10.1016/S0040-4039(00)74040-8>
• Heathcock Clayton H.: Die faszinierenden Alkaloide aus Yuzuriha. Angew Chem 1992, 104, 675. <http://dx.doi.org/10.1002/ange.19921040604>
• Hamel Ernest: Natural products which interact with tubulin in the vinca domain: Maytansine, rhizoxin, phomopsin a, dolastatins 10 and 15 and halichondrin B. Pharmacol Ther 1992, 55, 31. <http://dx.doi.org/10.1016/0163-7258(92)90028-X>
• Aicher Thomas D., Buszek Keith R., Fang Francis G., Forsyth Craig J., Jung Sun Ho, Kishi Yoshito, Scola Paul M.: Synthetic Studies towards Halichondrins: Synthesis of the C.27–C.38 Segment. Tetrahetron Lett 1992, 33, 1549. <http://dx.doi.org/10.1016/S0040-4039(00)91671-X>
• Buszek Keith R., Fang Francis G., Forsyth Craig J., Jung Sung Ho, Kishi Yoshito, Scola Paul M., Yoon Suk Kyoon: Synthetic Studies Towards Halichondrins: Synthesis of the Left Half of Halichondrins. Tetrahetron Lett 1992, 33, 1553. <http://dx.doi.org/10.1016/S0040-4039(00)91672-1>
• Fang Francis G., Kishi Yoshito, Matclich Michael C., Scola Paul M.: Synthetic Studies Towards Halichondrins: Synthesis of the Left Halves of Norhalichondrins and Homohalichondrins. Tetrahetron Lett 1992, 33, 1557. <http://dx.doi.org/10.1016/S0040-4039(00)91673-3>
• Burke Steven D., Buchanan John L., Rovin Joshua D.: Synthesis of a C(22)a˚C(34) halichondrin precursor via a double dioxanone-to-dihydropyran rearrangement. Tetrahetron Lett 1991, 32, 3961. <http://dx.doi.org/10.1016/0040-4039(91)80600-B>
• Cooper Arthur J., Salomon Robert G.: Total synthesis of halichondrins: Enantioselective construction of a homochiral pentacyclic C1-C15 intermediate from d-ribose. Tetrahetron Lett 1990, 31, 3813. <http://dx.doi.org/10.1016/S0040-4039(00)97476-8>
• Fusetani N., Yasumuro K., Matsunaga S., Hashimoto K.: Mycalolides A – C, hybrid macrolides of ulapualides and halichondramide, from a sponge of the genus . Tetrahetron Lett 1989, 30, 2809. <http://dx.doi.org/10.1016/S0040-4039(00)99131-7>
• Kim Seokchan, Salomon Robert G.: Total synthesis of halichondrins: Highly stereoselective construction of a homochiral pentasubstituted H-ring pyran intermediate from α-d-glucose. Tetrahetron Lett 1989, 30, 6279. <http://dx.doi.org/10.1016/S0040-4039(01)93872-9>
• FUSETANI NOBUHIRO: Antifungal Substances from Marine Invertebrates. Ann N Y Acad Sci 1988, 544, 113. <http://dx.doi.org/10.1111/j.1749-6632.1988.tb40395.x>
• Mangold Helmut K., Weber Nikolaus: Biosynthesis and biotransformation of ether lipids. Lipid 1987, 22, 789. <http://dx.doi.org/10.1007/BF02535533>
• Kato Yuko, Fusetani Nobuhiro, Matsunaga Shiegeki, Hashimoto Kaneshisa, Sakai Ryuichi, Higa Tatsuo, Kashman Yoel: Antitumor macrodiolides isolated from a marine sponge sp.: Structure revision of misakinolide A. Tetrahetron Lett 1987, 28, 6225. <http://dx.doi.org/10.1016/S0040-4039(00)61853-1>
• Aicher Thomas D., Kishi Yoshito: Synthetic studies towards halichondrins. Tetrahetron Lett 1987, 28, 3463. <http://dx.doi.org/10.1016/S0040-4039(00)96327-5>